Divarasib in the Evolving Landscape of KRAS G12C Inhibitors for NSCLC
Sign Up to like & getrecommendations! Published in 2024 at "Targeted Oncology"
DOI: 10.1007/s11523-024-01055-y
Abstract: Kristen Rat Sarcoma viral oncogene (KRAS) mutations are one of the most common oncogenic drivers found in 12–14% of non-small cell lung cancer (NSCLC) and 4% of colorectal cancer tumors. Although previously difficult to target,… read more here.
Keywords: divarasib evolving; kras g12c; evolving landscape; landscape kras ... See more keywords